NFE2L2 and small cell lung carcinoma: In these contexts, the growth and the progression of SCLC was demonstrated to be related to the well-known molecular KEAP1/NRF2 axis, a master regulator of antioxidants and cellular stress responses, also implicated in the resistance of tumor cells against chemo- and radiotherapies [18,19].